Compare Cipta Sarana Medika Tbk. (DKHH) vs Multi Indocitra Tbk. (MICE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cipta Sarana Medika Tbk. vs Multi Indocitra Tbk. — how do they compare? Cipta Sarana Medika Tbk. trades at Rp64 (market cap 160.67B, 14.05M 24h volume), while Multi Indocitra Tbk. trades at Rp520 (market cap 312B, 100 24h volume). The key difference: Multi Indocitra Tbk. is the larger of the two by market cap, and Cipta Sarana Medika Tbk. is more actively traded (14.05M versus 100). Which is the better fit depends on your goals.
| DKHH | MICE | |
|---|---|---|
Market Cap | 160.67B | 312B |
Volume | 14.05M | 100 |
Lot | 140.49K | 1 |
Turnover | 899.67M | 52K |
Average Price | 64.04 | 520 |
Value | 899.67M | 52K |
Indicative Equilibrium Price | 64 | — |
Indicative Equilibrium Volume | 100 | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cipta Sarana Medika Tbk.
PT Cipta Sarana Medika Tbk (the Company) was established based on Deed No. 90 dated September 17, 2014 by Dede Fujianti, SH., M.Kn., Notary in Sukabumi. The Company ultimate parent entity is PT Siliwangi Djajakusumah Bersatu. The Company started its commercial operations in 2014.
Read more on DKHH →About Multi Indocitra Tbk.
PT Multi Indocitra Tbk (the Company) was established under its original name of Modern Indocitra based on notarial deed No. 52 of Esther Daniar Iskandar, S.H dated January 11, 1990. The Company's articles of association has been amended several times, the latest amendment dated Aug 16, 2005, regarding the change in the Company's status from private company to public company.
Read more on MICE →
